Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government what assurances they have received from companies about how many vaccinations for COVID-19 it will be possible to manufacture and produce in the UK by December.

Owing to commercial sensitivities the Government is not able to reveal such information concerning vaccine developers at this time. The Vaccines Taskforce has taken action to scale up UK vaccine manufacturing capabilities, so that if and when a vaccine is found it can be produced at pace. This includes funding to accelerate and expand the new Vaccine Manufacturing and Innovation Centre, bring online a Rapid Deployment Facility, and a new state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing. Government has also partnered with Wockhardt to provide fill and finish services.